Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy. | Clin Cancer Res | 2011 | 0.92 |
2 | The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo. | Pigment Cell Melanoma Res | 2014 | 0.77 |